.:: TuttoCongressi ::.

Hai dimenticato la password? | Registrati

E-mail

Password

Resta Collegato

Cerca per parole nell'archivio:

In archivio:

N° Relazioni: 792
N° Accessi Relaz.: 155708

ISGE 2006

02/03/2006 - 05/03/2006

	Programma Evento
	Info

Mostra tutti | Mostra contenuti EasyRec

02/03/2006

Auditorium

11:00 - 13:00
POSSIBILITIES & CHALLENGES WITH ORAL CONTRACEPTION

Fruzzetti F.
Menstrual cycle suppression

Skouby S.
Epidemiology and treatment of PMS/PMDD

Busacca M.
Epidemiology and treatment of endometriosis and pelvic pain

Maudelonde T.
Non-contraceptive benefits of oral contraceptives

14:00 - 16:00
THE ROLE OF EFFICACY, SAFETY AND COST IN ART: CHOICE OF THE GONADOTROPHINS

Cortvrindt R.
Bioactivity of the HP urinary FSH (Fostimon®) versus the recombinant FSH (Gonal-F®) evaluated by the Follicle Bioassay

Iammarrone E.
Cost influences the choice of gonadotrophins (urinary versus recombinant) used in ART treatment in the United Kingdom

Urbancsek J.
What's the principle for selecting u-FSH or r-FSH in ART: recent clinical evidences in women undergoing controlled ovarian stimulation for IntraCytoplasmic Sperm Injection (ICSI)

Diedrich K.
The choice between recombinant versus urinary gonadotrophins - impact on IVF-treatment costs in Germany

De Mouzon J.
In vitro fertilization in France: economic aspects and influence of the gonadotrophin choice (urinary versus recombinant) on cost

Onice

11:00 - 13:00
ORAL PRESENTATIONS - CURRENT RESEARCH IN INFERTILITY AND ENDOMETRIOSIS

Bagchi C.
Endothelin-2, a progesterone-regulated paracrine factor in mouse ovary, plays a critical role in ovulation

Alviggi C.
A common genetic variant of LH b-subunit and controlled ovarian stimulation: retrospective study of prevalence in women with different profiles of follicular growth

Grygielko E.
Pharmacological validation and transcriptional analyses of preclinical models of estrogen opposition

Salata I.
Serum Concentrations of Matrix Metalloproteinases (MMP-2, MMP-9) And Their Inhibitors (TIMP-1, TIMP-2) Do Not Reflect The Severity of Endometriosis

Goulis D.G.
Reduced levels of inhibin-B and correlation with testicular cytology in subfertile men

Goulis D.
The use of Data Mining in the categorization of patients with azoospermia

Nabhan A.
Correlation between Hormonal Markers of Ovarian Reserve and the Antral Follicle Count

14:00 - 16:00
SPECIAL SYMPOSIUM SOBRAGE - EXTENDED USE OF HORMONAL CONTRACEPTION

Bonassi R.
The concept of extended use of hormonal contraception

Geribela A.
Clinical acceptability of extended use of hormonal contraception

Spinola P.
Clinical acceptability of injectable contraceptives

Hugo M.
Local estrogen production, uterine pathology and treatment using extended use of hormonal contraceptives

17:00 - 19:00
ORAL PRESENTATIONS - MENOPAUSE IN 2006

Muscat Baron Y.
Intervertebral Disc Height in Postmenopausal Women with Osteoporotic Vertebral Fractures

Nijland E.
Effects of tibolone and continuous combined estrogen-progestin therapy (ept) on quality of life and sexual function

Wildemeersch D.
Maximizing the benefits and acceptability of HRT while reducing the risk to a minimum: an easily applicable solution for a major public health problem

Virtej I.
Subclinical hypothyroidism in postmenopausal women ? effects on plasma lipid profile are modified by insulin resistance

Vujovic S.
Premenstrual syndrome, sexuality and premature ovarian failure

Di Carlo C.
Postmenopausal hypoestrogenism increases vasoconstricting and decreases vasodilatory neuropeptides content in the arterial wall autonomic terminations

Caruso S.
Steroids, olfaction and sexuality

PalazzoAffari

11:00 - 13:00
THE MENOPAUSAL BRAIN

Rossmanith W.
The human menopause - a primary neuroendocrine event?

Genazzani A.
Neurosteroid synthesis and action in the menopausal brain

Maki P.
CNS structure and function after the menopause

14:00 - 16:00
NOVO NORDISK SATELLITE SYMPOSIUM - LOCAL OESTROGENS: QUO VADIS?

Archer D.
Evolving evidence useful for counseling on Hormone Therapy

Ulrich L.
Symptoms and treatment of local estrogen deficiency

Guidozzi F.
Atrophic vaginitis: a growing problem?

Nappi R.
Sexual dysfunction in long term users of oral contraceptives

16:20 - 16:50
PLENARY LECTURE - BRUNO LUNENFELD: THE ANDROGEN DEFICIENCY SYNDROME IN THE AGING MALE

Lunenfeld B.
The androgen deficiency syndrome in the aging male

17:00 - 19:00
MOLECULAR ENDOCRINOLOGY: CLINICAL IMPACT

Diaz Brinton R.
Estrogens and The Brain: Healthy Cell Bias of Estrogen Action

Simoncini T.
How steroid signaling in vascular cells predicts the clinical effects of HRT

Thijssen J.
Progesterone receptors in the human

Verde

11:00 - 13:00
OVARIAN DEVELOPMENT, MATURITY AND AGING

Leung P.
Multi-faceted role of GnRH1 and 2 in the human ovary

Pangas S.
TGFbeta Superfamily Regulation of Ovarian Folliculogenesis

Barri P.
Reproduction of the ageing patient

14:00 - 16:00
THE BONE AS A TARGET OF REPRODUCTIVE HORMONES

Gambacciani M.
Hormonal contraception and bone health

Christiansen C.
Bone health after the menopause and hormone replacement therapy

16:20 - 16:50
MELBROSIN SPONSORED LECTURE - MARTIN IMHOF

Imhof M.
Clinical action and safety of red clover isoflavones

03/03/2006

Auditorium

08:30 - 10:00
SPECIAL SESSION - MENOPAUSE HORMONE THERAPY BEYOND WHI

Gambacciani M.
Is ERT/HRT an option for prevention and treatment of Osteoporosis after WHI

Brincat M.
Significance of changes in connective tissue with the menopause and with HRT

Genazzani A.R.
New HRT Options for the Treatment of Menopausal Symptoms and the Maintenance of Quality of Life in Postmenopausal Women

10:10 - 10:40
PLENARY LECTURE - RICHARD FARMER: CAN HRT BE REHABILITATED?

Farmer R.
Can HRT be rehabilitated?

11:00 - 13:00
ORGANON SATELLITE SYMPOSIUM - TIBOLONE: NEW RESULTS FROM KEY CLINICAL TRIALS

Morris E.
Tibolone versus estrogen-progestin therapy ? what has been investigated so far?

Hammar M.
A randomized comparative study with tibolone and a low dose continuous combined estrogen-progestin therapy (EPT)

Adami S.
Effects of tibolone and raloxifene on bone: results of the step study

14:00 - 16:00
SOLVAY SATELLITE SYMPOSIUM - LONG TERM BENEFITS AND RISKS OF FEMOSTON

Simoncini T.
Are progestins all the same? Lessons from the vascular system

Stevenson J.
Oestradiol 17β plus cyclical dydrogesterone HRT and its effect on lipid parameters

Berga S.
The Brain as a Target Tissue of Sex Steroids

Onice

08:30 - 10:00
ORAL PRESENTATIONS - RECENT PROGRESSES IN CONTRACEPTION

Rad M.
Effects on risk markers for venous and arterial disease and on estrogenicity markers of a vaginal ring delivering Nesterone and ethinyl estradiol in comparison with a combined oral contraceptive containing levonorgestrel

Kluft C.
Hemostasis effects of oral contraceptives containing drospirenone in combination with either 30 or 20 µg ethinylestradiol and a reference containing desogestrel and 30 µg ethinyl estradiol

Rad M.
Metabolic Effects of the Continuous Use of a Low-dose Levonorgestrel (LNG)/Ethinyl Estradiol (EE) Oral Contraceptive (OC) in a Randomized Study

Schilling A.
The efficacy and safety of ethinylestradiol/chlormadinone acetate (Belara®): Results of a non-interventional trial in four Latin-American countries

Gruber D.
Cycle control of two 21-day COC regimens, both containing ethinyloestradiol 20µg one with drospirenone 3mg and one with desogestrel 150µg

Rajaei L.
Evaluation of side effects of low dose contraceptive pills administered by the vaginal route

11:00 - 13:00
SPECIAL SYMPOSIUM - THE EUROPEAN SOCIETY OF GYNAECOLOGY: HORMONAL ASPECTS OF BREAST CANCER (INTERACTIVE, CASE BASED SYMPOSIUM)

14:00 - 16:00
ORAL PRESENTATIONS - FRONTIERS IN CANCER RESEARCH

Hill S.
Estrogen Receptor Transactivation Regulation By Melatonin Involves In G Protein Coupled Signal Transduction Pathway In Endometrial Cancer

Choi J.
Gonadotropins: the role and molecular mechanism in normal and neoplastic ovarian epithelium cells

Tsigkou A.
Inhibin alpha, a new serum marker for prostate cancer?

Martineti V.
Action of two isoflavonoids on human HCT8 colon cancer cell lines over-expressing ERb

Cosio S.
Is p53 gene status a predictive or prognostic variable for patients with poorly differentiated, advanced serous epithelial ovarian cancer treated with paclitaxel- plus platinum-based chemotherapy ?

17:00 - 19:00
SPECIAL SYMPOSIUM EN LANGUE FRANÇAISE - SOCIÉTÉ FRANCOPHONE DE CONTRACEPTION (SOUS RÉSERVE D'ACCORD DES INTERVENANTS): CONTRACEPTION - INNOVATIONS ET INTERROGATIONS

Sitruk Ware R.
Implants contraceptifs pour homme et pour femme

Bouchard P.
Les anti-progestérones de nouvelle génération : leur intérêt en contraception

Serfaty D.
Le CIRC (Centre International de Recherche contre le Cancer) et la cancérogénécité de la pilule

Bitzer J.

PalazzoAffari

08:30 - 10:00
PRE-MENSTRUAL SYNDROME, POST-NATAL AND POST-MENOPAUSAL DEPRESSION AND OTHER HORMONE-RELATED DYSPHORIC DISORDERS

Facchinetti F.
Premenstrual changes: towards a different approach

Studd J.
Hormonal treatment of severe premenstrual syndrome

Nappi R.
Post-partum depression

10:10 - 10:40
PLENARY LECTURE - SARAH BERGA: THE ROLE OF THE CENTRAL NERVOUS SYSTEM IN THE PATHOGENESIS OF POLYCYSTIC OVARY SYNDROME

Berga S.
The role of the central nervous system in the pathogenesis of polycystic ovary syndrome

11:00 - 13:00
GENOMIC AND PROTEOMIC APPROACHES TO THE DIAGNOSIS AND TREATMENT OF GYNECOLOGICAL CANCER

Tsang B.
Deciphering the molecular and cellular mechanisms of chemoresistant ovarian cancer

Konishi I.
Molecular genetics in the development of the two types of endometrial carcinoma

Faragher R.
Microarray analysis of replicative senescence

Kalogeropoulos S.
Telomerase Activity, Telomere Length and Degree of Aneuploidy in Ovarian Adenocarcinomas

14:00 - 16:00
HYPERINSULINEMIA AND INSULIN RESISTANCE: A CHALLENGE IN GYNECOLOGICAL ENDOCRINOLOGY

Goverde A.
Consequence of hyperinsulinemia in anovulatory PCOS

Skouby S.
Steroid hormone use in insulin resistant women: clinical issues

Benedetto C.
Insulin sensitizing agents during pregnancy

Angioni S.
Ovarian stromal hypertrophy and insulin abnormalities in pcos

16:20 - 16:50
ROTTAPHARM SPONSORED LECTURE - A CATAPANO: DYSLIPOPROTEINEMIAS: DIETARY & NUTRITIONAL APPROACHES

Catapano A.
Dyslipoproteinemias: dietary & nutritional approaches

17:00 - 19:00
THE OBESE PATIENT CLINICAL ISSUES IN REPRODUCTIVE ENDOCRINOLOGY

Niswender K.
Biological and evolutionary basis of body weight homeostasis

Creatsas G.
Menstrual cycle disorders in the PCO obese adolescents

Marconi A.
The obese patient during pregnancy

Milewicz A.
Clinical implications of obesity after the menopause

Fulghesu A.
Endocrine and metabolic aspects in obese and lean young PCOS

Quattro

11:00 - 13:00
ORAL PRESENTATIONS - CLINICAL ISSUES IN GYNECOLOGICAL ENDOCRINOLOGY

Loverro G.
Inhibitory effect of obesity on gonadotropin, estradiol and inhibin b levels in fertile women

Crivelli M.
Hiv infection, stress and reproduction

Garcia M.
Decreased Subjective and Objective Measurements of Sexual Function and Testosterone Levels in Hypopituitary Women

Naessén S.
Endocrine and nutrition-related determinants of bone mineral density in bulimic women

Tropea A.
Androgens decrease vegf expression and secretion in human luteal cells

Dabkowska-Huc A.
The influence of endogenous testosterone on the gene expression for 5-a-reductase type 1 and 2 in hair papillae from lower abdominal region of the skin among women with hirsutism

Romualdi D.
Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome

De Falco M.
Preoperative treatment of uterine leiomyomas: clinical findings and expression of TGF-β3 and CTGF

14:00 - 16:00
ORAL PRESENTATIONS - FROM GAMETES TO PREGNANCY: ART IN 2006

Cheong M.
Analysis of human telomerase reverse transcriptase (hTERT) mRNA expressions in the endometrim of endometriosis

Campo S.
Short-term and long-term results of laparoscopic surgery of endometriomas

Yadav RK.
Serum leptin levels in pelvic endometriosis: An Indian experience

Soares A.
Effects of coasting on assisted reproduction outcome

Lockwood G.
Optimising outcome of IVF-ET treatment cycles in ?poor responders'

Verde

08:30 - 10:00
PUBERTY AND PRIMARY AMENORRHEA

Apter D.
Normal and abnormal pubertal development: clinical and hormonal assessment

Baroncelli G.
Strategies to improve skeletal development in girls and adolescents with abnormal pubertal development

Bruni V.
Clinical treatment to improve the reproductive phenotype in abnormal pubertal development and in women with primary amenorrhea

Ben-Rafael Z.
Pregnancy in Turner syndrome and gonadal dysgenesis: strategies and therapies

10:10 - 10:40
PLENARY LECTURE - LISELOTTE METTLER: OVARIAN SURGERY AND FOLLICULAR RESERVE

Mettler L.
Ovarian surgery and follicular reserve

11:00 - 13:00
REPRODUCTIVE SURGERY

Garcia Velasco J.
Ovarian drilling: a critical review

Gargiulo T.
Symptomatic pelvic congestion syndrome: surgical management

14:00 - 16:00
HORMONES AND ENDOMETRIOSIS

Petraglia F.
Hormonal treatments and endometriosis

Taylor R.
Nuclear receptor actions in endometriosis

Schindler A.
Mode of application of GnRH agonists for the treatment of endometriosis

Lanzone A.
Paracrine regulation of endometriotic tissue

Cela V.
Management of surgically treated endometriosis patients

17:00 - 19:00
GENETIC VARIABILITY IN GYNECOLOGICAL ENDOCRINOLOGY

Huber J.
The impact of genetic variability and gynecological endocrinology

Brandi M.
Genetics of Osteoporosis

Di Blasio A.
Genetic factors related to endometriosis

Herrington D.
Pharmacogenomics of hormone replacement therapy

Pertynski T.
Antigen levels of matrix metalloproteinase 1 and its gene polymorphisms and endometrial bleeding in hormone replacement therapy users

04/03/2006

Auditorium

08:30 - 10:00
SPECIAL SESSION - NEW ADVANCES IN MENOPAUSE RESEARCH

Wuttke W.
Black cohosh for the treatment of climacteric complaints and osteoporosis

Tian Q.
Long-term low-dose HRT protects the cardiovascular system in post-menopausal women

10:10 - 10:40
ROTTAPHARM SPONSORED LECTURE - ALESSANDRA GRAZIOTTIN: NEW ADVANCES IN PHYTOESTROGENS THERAPY

Graziottin A.
New advances in phytoestrogens therapy

11:00 - 13:00
MERCK THERAMEX SPONSORED SYMPOSIUM - ADVANTAGES OF CONTINUOUS COMBINED TRANSDERMAL HORMONAL THERAPY

Genazzani A.
The impact of transdermal hormone administration on CNS

Speroff L.
Transdermal vs Oral Postmenopausal Hormone Therapy. Is There a Clinical Difference?

Onice

08:30 - 10:00
SPECIAL SYMPOSIUM SIGITE - EPIDEMIOLOGY OF MENOPAUSE IN ITALY: FINDINGS FROM PROGETTO MENOPAUSA ITALIA

Lello S.
Depression during menopausal transition

Parazzini F.
Epidemiology of menopause and hormonal treatment

Becorpi A.
Lowbone density and osteoarthritis in postmenopausal women

Baldi S.
Cardiovascular riskfactors and menopause

11:00 - 13:00
SPECIAL SYMPOSIUM ISPOG - WHEN AND WHY FOR A PSYCHOSOMATIC APPROACH IN GYNECOLOGY

Peters A.
Psychosocial factors on the course of pre malignant cervical lesions

Bitzer J.
Menopausal medicine and psychosomatics - challenges and link

Damonte C.
Quality of life in menopause: is it possible to quantify?

Horner E.
Recent and future advances in the treatment of premenstrual syndrome

14:00 - 16:00
SPECIAL SYMPOSIUM OGASH - INTERCONTINENTAL SOCIETY FOR THE STUDY OF GESTOSIS

El-Kabarity H.
Feto-Maternal Immunologic Dialogue Part II Humeral and Cellular immunologic response in EPH-Gestosis

Cosmi E.
The role of hormones on fetal lung maturity (FLM)

17:00 - 19:00
SPECIAL SYMPOSIUM POLISH GYNECOLOGIC SOCIETY

Drews K.
Hormonal and genetic screening ? new insights in pregnancy and preterm birth

Jakimiuk A.
Endocrine aspects of dysfunctional uterine bleeding (DUB): etiopathology and treatment

Paszkowski T.
Future of HRT - how far can we go down with the dose?

PalazzoAffari

08:30 - 10:00
UTERINE MYOMAS: BIOLOGICALLY-DRIVEN THERAPEUTICAL APPROACHES

Di Carlo C.
Newer approaches for the treatment of uterine myomas

Mettler L.
Comparison of surgical treatments of fibroids

10:10 - 10:40
SOLVAY SPONSORED LECTURE - JULIA SZEKERES-BARTHO: HOW DO THE IMMUNOLOGICAL ASPECTS OF DYDROGESTERONE IMPACT NORMAL PREGNANCY?

Szekeres-Bartho J.
How do the immunological aspects of dydrogesterone impact normal pregnancy?

11:00 - 13:00
EMBRYO DEVELOPMENT, IMPLANTATION AND EARLY PREGNANCY LOSS

Dey S.
Molecular roadmap to embryo implantation

Yeung W.
Complement protein 3 - an oviductal paracrine factor regulating embryo development

14:00 - 16:00
AMSA/IBSA SATELLITE SYMPOSIUM - PROGESTERONE USE IN REPRODUCTIVE MEDICINE: LOOKING FOR THE BEST WAY OF ADMINISTRATION

De Ziegler D.
Progesterone benefits in IVF cycles: an issue of dose and way of administration

Carp H.
Progesterone use in recurrent miscarriage

17:00 - 19:00
THE BREAST AS A HORMONAL TARGET IN PHYSIOLOGY AND DISEASE

von Schoultz B.
Principles for individual variations in the breast response to hormonal treatments

Sismondi P.
Antihormones in prevention and treatment of breast cancer

Quattro

11:00 - 13:00
ORAL PRESENTATIONS - GYNECOLOGICAL CANCERS: THE ROAD AHEAD

Zervoudis S.
Cross talk between signaling pathways and the development of chemoresistance in breast cancer

Fu X.
The effects of progesterone and medroxyprogesterone acetate on moesin activation and rapid actin cytoskeleton remodelling in human endothelial cells and t-47-d breast cancer cells

Picariello L.
Effects of 17 ßE2 and Raloxifene on Desmoid Tumour Derived cells

Miyamoto T.
Mismatch repair activity is accelerated by estrogen stimulation in normal and malignant endometrial glandular cells

Nowak-Markwitz E.
Co-expression of hCGß and LH/hCG receptor in epithelial ovarian cancer cells

Huser M.
Gonadal protection with CNRh analogues during chemotherapy ? cytotoxic dose derived cohort study (Ovaronko)

14:00 - 16:00
ORAL PRESENTATIONS - MENOPAUSAL SYNDROME: BIOLOGICAL BASIS

Hestiantoro A.
Neurons surrounded by basket-like estrogen receptor (ER)β containing terminals in the hypothalamic infundibular nucleus are not affected by neurofibrillary Alzheimer's disease pathology

Mannella P.
Estrogen Receptor Protein Interaction with PI3K Leads to Activation of pAkt and pERK1/2 in the Same Population of Cortical Neurons: A Unified Mechanism of Estrogen-Action

Bogusiewicz M.
Influence of estrogen receptor α polymorphism on serum levels of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in postmenopausal women taking tibolone or raloxifen - preliminary study

Stomati M.
Effects of low-dose oral deydroepiandrosterone (DHEA) in postmenopausal women

Milan A.
Baroreflex sensitivity in post-menopausal hypertensive women is reduced according to central fat distribution

Drews K.
The significance of calcitonin receptor polymorphism in postmenopausal women

Pluchino N.
Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels

Hayashida S.
Hepatic function with cimicifuga racemosa in postmenopausal patients

Lenzi E.
Effect of MAP and Dydrogesterone administration on central and peripheral content of allopregnanolone and beta-endorphin

Tempone A.

Verde

08:30 - 10:00
CHRONIC ANOVULATION IN BODY WEIGHT DISTURBANCES

Brambilla F.
Psychoneuroendocrine aspects of amenorrhea in anorexia nervosa

Casanueva F.
The role of leptin and ghrelin in the regulation of gonadal function

Shoham Z.
Reproductive outcome in women with body weight disturbances

Lello S.
Estrogens and progestins as a prevention and treatment option in body weight disturbances in women

10:10 - 10:40
MERCK THERAMEX SPONSORED LECTURE - MARC ESPIE: MISSION STUDY : INITIAL RESULTS ON THE PREVALENCE OF BREAST CANCER

Espie M.
MISSION Study : initial results on the prevalence of breast cancer

14:00 - 16:00
MENORRHAGIA AND ABNORMAL UTERINE BLEEDINGS

Scarselli G.
Abnormal uterine bleeding: diagnosis and treatment

Sturdee D.
The merits of intrauterine progestogen

Laudanski T.
Bleeding pattern and myometrial contractility - pathophysiology and new treatment strategies in dysmenorrhoeic patients

Druckmann R.
Progestins in menorrhagia and abnormal uterine bleedings

17:00 - 19:00
HYPOTHALAMIC AMENORRHEA

Berga S.
Brain signals mediating stress-induced anovulation

Genazzani A.D.
Endocrine and neuroendocrine diagnostic tools for the assessment of stress induced amenorrhea

Rickenlund A.
Hypothalamic amenorrhea-its relation to physical exercise and sport

Filicori M.
Treatment of infertility in hypothalamic amenorrhea

Schenker J.
Prolactinomas, clinical manifestations and treatment

05/03/2006

Auditorium

08:30 - 10:30
SEX STEROIDS AND THE CARDIOVASCULAR SYSTEM

Lobo R.
Body mass, adipocytokines and cardiovascular risk in polycystic ovary syndrome (PCOS)

Stevenson J.
Cardiovascular health after menopause: lessons learnt for clinical practice

Agnusdei D.
SERMs and cardiovascular system

10:00 - 11:00
OPENING CEREMONY - OPENING LECTURE BY PROF LEON SPEROFF: THE FUTURE OF POSTMENOPAUSAL HORMONE THERAPY IT'S TIME TO MOVE FORWARD

Speroff L.
The Future of Postmenopausal Hormone Therapy It's Time to Move Forward

11:30 - 13:30
THE CLIMACTERIC WOMAN: TREATMENT OPTIONS IN 2006

Birkhaeuser M.
Biological basis and clinical approach to climacteric symptoms

Palacios S.
Perspectives of the new SERMs

Brincat M.
Inter-vertebral disc space in the menopause and HRT

Schneider H.
The role of androgens and antiandrogens

Pines A.
Hormone replacement in 2006: where do we stand?

Neves-e-Castro M.
What has experience taught us

Onice

08:30 - 10:30
ORAL PRESENTATIONS - RECURRENT ABORTION AND HIGH-RISK PREGNANCY IN THE THIRD MILLENNIUM

Ginocchini L.
Recurrent pregnancy loss, new orizons

Bagchi M.
C/EBP Beta is a Critical Mediator of Steroid Hormone-Regulated Cell Proliferation and Differentiation in the Uterine Epithelium and Stroma

Hardman B.
Insulin Regulates Copper Transporters in Human Placenta: A Novel Role for this Hormone in the Regulation of Copper Transport During Pregnancy

Stefanidis K.
Oxytocin receptor and TRA-1-81 antigen expression in amniotic fluid cells

Parizek A.
Serum free and conjugated 20-hydroxy-derivatives of pregnenolone, progesterone and their neuroactive reduced metabolites in the third trimester of human pregnancy

Stjernholm Y.V.
Mitogen activated protein kinase signaling pathways are activated in human uterine cervix at parturition

Costantino M.
Alexithymia and biopsychological functions in a large group of pregnant women from southern italy: is there a direct relation with fetal heart rate and variability?

Nasiri Amiri F.
The Sexual Behavior Associated With Urinary Tract Infection in Pregnant Women

11:30 - 13:30
ORAL PRESENTATIONS - MOLECULAR ENDOCRINOLOGY OF WOMEN

Aghajanova L.
Functional thyroid hormone receptors are present in human ovarian tissue

Kluft C.
Estrogen receptor-1 genotypes do not influence baseline levels of hemostasis and lipid risk markers for cardiovascular disease in young women

Begliuomini S.
Changes of Brain-Derived Neurotrophic Factor throughout ovarian cycle: does it exist a relationship with sex hormonal variations?

Limpaphayom K.
Urogynecology in Menopause : Prevalence of lower urinary tracts symptoms (LUTS)

Kovács K.
Differential expression of Forkhead (FKHR) transcription factors in human endometrium and myometrium

PalazzoAffari

08:30 - 10:30
ASSISTED REPRODUCTION: PHARMACOLOGICAL AND TECHNICAL APPROACHES FOR SAFETY AND FERTILITY PRESERVATION

Artini P.
Growth factors and follicologenesis in PCO patients

Devoto L.
Human corpus luteum function in assisted reproduction

Szamatowicz M.
"Theft" of the reproductive time of women as a result of unproper treatment of infertility

Papanikolaou E.
Early progesterone rise in the follicular phase in IVF cycles and impact on the pregnancy outcome

Lewin A.
Oocytes donation - a model for the study of factors related to oocyte-sperm interaction, embryo quality and implantation

11:30 - 13:30
CURRENT TRENDS IN CONTRACEPTION

Fruzzetti F.
Estro-progestin Contraception

Lachowsky M.
What contraception means to adolescents

Spinola P.
Long-lasting contraception

Siseles N.
Perimenopausal contraception

Ho P.
Emergency contraception

Anderson R.
Male contraception

Verde

08:30 - 10:30
ORAL PRESENTATIONS - PCOS: FROM THE BENCH TO THE BEDSIDE

Maher J.
Characterization of Fem1 expression in the ovary

Ferraz M.
Polymorphism of the insulin receptor gene in brazilians patients with the polycystic ovary syndrome and hiperandrogenism, insulin resistance and acantosis nigricans (HAIR-AN syndrome)

Spritzer P.
Calpain-10 gene UCSNP-43 and UCSNP-19 polymorphisms in polycystic ovary syndrome (PCOS)

Pellatt L.
Anti-müllerian hormone (amh) production was significantly increased in anovulatory polycystic ovaries compared to normal ovaries: role of amh in regulating follicle selection?

Villa P.
Relevance of ovarian volume in ultrasound diagnosis of pcos in adolescence

Szilagyi A.
Three dimensional (3D) ultrasound in patients with polycystic ovary syndrome (PCOS); effects of metformin treatment on ovarian volume and blood flow

Nilas L.
Polycystic ovary syndrome (PCOS), insulin resistance (IR), clinical or biochemical hyperandrogenism is not associated with alterations in bone mass density (BMD)

Seaman H.
The risk of venous thromboembolism amongst women with polycystic ovary syndrome

11:30 - 13:30
SPECIAL SYMPOSIUM SIERR - ART: LESSONS FROM THE OOCYTE

Lanzone A.
Intraovarian dysregulation of follicle maturation

Ebner T.
The predictive value of basal anti-Müllerian hormone (AMH) on oocyte quality and further development

Focarelli R.
A multidisciplinary approach to the evaluation of the cryopreserved versus fresh human oocyte